Hypertension, Albuminuria Common in Pediatric Type 2 Diabetes
The prevalence of hypertension and albuminuria in pediatric patients with type 2 diabetes varies by race.
Pediatrics
Predictors of Poor Renal Outcomes in Pediatric Lupus Nephritis Identified
Researchers studied the clinical features, treatment modalities, and long-term renal outcomes of pediatric patients with lupus nephritis.
FDA Approves New Indication for Myrbetriq in Children With NDO
Extended-release tablets and extended-release oral suspension forms approved to treat neurogenic detrusor overactivity in children 3 years and older
COVID-19 Impacting Caregivers of Children With Cancer
Changes to medical care, financial disruptions, and emotional distress reported
Tobacco Exposure Tied to Hypertension in Children
Findings based on study of more than 8500 children ages 8 to 19 years.
NSAID May Increase AKI Risk in Hospitalized Children
Avoiding inappropriate use and overdosing of drugs with nephrotoxic effects is an important strategy to prevent hospital-acquired AKI in children, according to investigators.
Botox Approved for Neurogenic Detrusor Overactivity in Pediatric Patients
The approval is supported by data from a phase 3 study that assessed the efficacy and safety of Botox in patients aged 5 to 17 years with urinary incontinence due to NDO and using clean intermittent catheterization.
Acute Kidney Injury Common in Children With Diabetic Ketoacidosis
Children with versus those without AKI have lower scores on tests of short-term memory during DKA
No Significant Difference Between Sitagliptin, Placebo in Pediatric T2D Trials
The alert was based on data from three 20-week double-blind, placebo-controlled studies each with 34-week extensions.
FDA: NSAID Use Should Be Avoided in Pregnancy Even Sooner Than 30 Weeks
The use of NSAIDs after 20 weeks of pregnancy may lead to low levels of amniotic fluid surrounding the baby resulting in kidney complications.
- Loading...
Loading...
Loading... 
Loading...